Removal of adrenal steroids from the medium reverses the stimulating effect of catecholamines on corticotropin releasing hormone neurons in organotypic cultures

Neuroendocrinology

Volumn 61, Issue 5, 1995, Pages 517-524

  Szafarczyk, Alain ^a   Feuvrier, Emmanitelle ^a   Siaud, Philippe ^a   Rondouin, Gérard ^b   Lacoste, Marlène ^a   Gaillet, Sylvie ^b   Malaval, Francis ^a   Assenmacher, Iyan ^a  

^a Endocrinological Neurobiology Laboratory URA1197CNRS ^*  (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Adrenal steroids; Catecholamines; Corticotropin releasing hormone

Indexed keywords

ARGIPRESSIN; CALCIUM ION; CATECHOLAMINE DERIVATIVE; CHARCOAL; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; EGTAZIC ACID; HYDROCORTISONE; NORADRENALIN; POTASSIUM ION;

ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL; NERVE FIBER; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; TISSUE CULTURE;

ADRENAL CORTEX HORMONES; ANIMAL; ARGIPRESSIN; CATECHOLAMINES; CORTICOTROPIN-RELEASING HORMONE; CULTURE MEDIA; HYPOTHALAMUS, ANTERIOR; IMMUNOHISTOCHEMISTRY; NEURONS; NOREPINEPHRINE; ORGAN CULTURE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029005273     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000126875     Document Type: Article

References (40)

1. Ganong WF, Dallman MF, Roberts JL: The hypothalamic-pituitary-adrenal axis revisited. Ann NY Acad Sci 1987;512:1-504.
2. Rose FC: The Control of the Hypothalamo-Pituitarv-Adrenocortical Axis. Madison International Universities Press, 1989.
3. Kvetnansky R. McCarty R. Axelrod J: Stress: Neuroendocrine and Molecular Approaches. New York. Gordon & Breach. 1992.
4. Vale W: Corticotropin-releasing factor (abstract). Ciba Found Symp 1992. p 172.
5. Ganong WF: Ncurotransmitter mechanisms underlying stress responses; in Brown GA. Ko-plow SH. Reichlin S (eds): Neurocndocrinology and Psychiatric Disorders. New York. Raven Press, 1984. pp 133-143.
6. Axelrod J. Reisine TD: Stress hormones: Their interaction and regulation. Science 1984:224: 452-459.
7. Antoni FA: Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endoer Rev 1986;7:351-377.
8. Alonso G. Szafarczyk A, Balmefrczol M. As-senmacher I: Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin-releasing hormone and vasopressin in rats. Brain Res 1986;397:297-307.
9. Guillaume V, Conte-DevoLx B, Szafarczyk A, Malaval F, Parès-HerbutćN, Grino M, Alonso G, Assenmacher I. Oliver C: The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines. Neurocndocrinology 1987;46:143-146.
10. Szafarczyk A. Malaval F, Laurent A, Gibaud R, Assenmacher I: Further evidence for a central stimulatory action of catecholamines on adrenocorticotropic release in the rat. Endocrinology 1987;121:883-892.
11. óaillet S, Malaval F, Barbancl G. Pelletier G. Assenmacher I. Szafarczyk A: Inhibitory interactions between tti-adrenergic and opioid but not NPY mechanisms controlling the CRF-ACTH axis in the rat. Regul Pept 1991;36:249-261.
12. Al-Damluji S: Adrenergic mechanisms in the control of corticotrophin secretion. J Endocrinol 1988:119:5-14.
13. Plotsky PM: Pathways to the secretion of adrenocorticotropin: A view from the portal. J Neuroendocrinol 1991;3:1-9.
14. Sawchcnko PE. Swanson LW: Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 1981;214:685-687.
15. Swanson LW, Sawchenko PE: Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983:6:269-324.
16. Liposits ZS, Phelix C. Pauli K: Adrenergic innervation of corticotropin-releasing factor-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat: A combined light and electron microscopic study. Histochemistry 1986;84:201-205.
17. Cunningham ET Jr. Sawchcnko PE: Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat's hypothalamus. J Comp Neurol 1988;274: 60-76.
18. Gaillet S, Alonso G, Le Borgne R. Barbancl G, Malaval F. Assenmacher I, Szafarczyk A: Effects of discrete lesions in the ventral noradrenergic ascending bundle on the corticotropic stress response depend on the site of the lesion and on the plasma levels of adrenal steroids. Neurocndocrinology 1993:58:408-419.
19. Stoppini L. Buchs PA. Muller D: A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991:37:173-182.
20. Calogero AE, Gallucci WT. Chrousos GP. Gold PW: Catecholamine effects upon rat hypothalamic corticotropin-relasing hormone secretion in vitro. J Clin Invest 1988:82:839-846.
21. Widmaicr EP, Lim AT. Vale W: Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: Effects of catecholamines. Endocrinology 1989:124:583-590.
22. Hu SB, Tannahill LA, Lightman SL: Mechanisms of norepinephrine-mediated corticotropin-releasing factor 41 release from cultured fetal hypothalamic cells. Neurocndocrinology 1992;56:712-718.
23. Walker SJ, Vrana KE: Pituitary corticotroph function during the stress hyporesponsive period in neonatal rats. Neurocndocrinology 1993: 57:1003-1010.
24. Jones MT, Gillham B, Campbell EA, Al Taher ARH. ChuangTT. Di Sciullo A: Pharmacoloy of neural pathways affecting CRH secretion. Ann NY Acad Sci 1987;512:162-175.
25. Suda T, Yatima TF, Tomori N, Sumitomo T, Nakagami Y, Ushivama T, Demura H, Shi-zume K: Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor from the rat hypothalamus in vitro. Life Sci 1987;40:1645-1649.
26. Alonso G, Szafarczyk A, Assenmacher I: Immunoreactivity of hypothalamo-ncurohypo-phvsial neurons which secrete corticotropin-releasing hormone (CRH) and vasopressin (Vp): Immunocytochemical evidence for a correlation with their functional state in colchicine-treated rats. Exp Brain Res 1986:61:497-505.
27. Kovacs K, Kiss JZ. Makara GB: Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of cor-ticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 1986:44:229-234.
28. Sapolsky RM, Armanini MP. Packan DR. Sutton SW. Plotsky PM: Glucocorticoid feedback inhibition of adrenocorticotropic hormone se-crctagogue release: Relationship to corticosteroid receptor occupancy in various limbic sites Neuroendocrinology 1990:51:328-336.
29. Pacak K. Kvetnansky R. Palkovits M. Fukuha-ra K, Yadid G. Kopin IJ, Goldstein DS: Adrenalectomy augments in vivo release of norepinephrine in the paraventricular nucleus during immobilization stress. Endocrinology 1993; 133:1404-1410.
30. VetrugnoGC, LachuerJ, PeregoC, Miranda E, De Simoni MG. Tappaz M: Lack of glucocorticoids sustains the stress-induced release of noradrenaline in the anterior hypothalamus. Neuroendocrinology 1993:57:835-842.
31. Jhanwar-Unival M, Renner KJ. Bailo MT Luine VN, Leibowitz SF: Corticosterone-dependent alterations in utilization of catecholamines in discrete areas of rat brain. Brain Res 1989:500:247-255.
32. Jhanwar-Uniyal M. Leibowitz SF: Impact of circulating corticosterone on α1-and α2-norad-renergic receptors in discrete brain areas. Brain Res 1986:368:404-408.
33. Stone EA. Egawa M, Colbjomsen CM: Catc-cholamine-induced desensitization of brain beta adrenoceptors in vivo and reversal by corticosterone. Life Sci 1989;44:209-213.
34. Pacak K. Armando I, Komoly S. Fukuhara K. Weise V. Holmes C, Kopin J, Goldstein D: Hypercorticosolemia inhibits vohimbine-in-duced release of norepinephrine in the posterolateral hypothalamus of conscious rats. Endocrinology 1992;131:1369-1376.
35. Mobley PL. Sulscr F: Adrenal corticoids regulate sensitivity of noradrenaline receptor-cou-pled andenylate cyclase in brain. Nature 1980; 286:608-609.
36. Duman RS, Strada SJ, Enna SJ: Glucocorticoid administration increases receptor-mediated and forskolin-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices. Brain Res 1989:477:166-171.
37. Cummings S, Seybold V: Relationship of alpha-1 and alpha-2 adrenergic binding sites to regions of the paraventricular nucleus of the hypothalamus containing corticotropin-releas-ing factor and vasopressin neurons. Neuroen-docrinology 1988;47:523-532.
38. Plotsky PM, Cunningham ET. Widmaier EP: Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endoer Rev 1989;10:437-458.
39. Lachuer J. Buda M. Tappaz M: Lack of glucocorticoids enhances the early activation of noradrenergic cell group triggered by restraint stress. J Neuroendocrinol 1992;4:153-159.
40. Joels M, De Kloet ER: Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 1989:245:1502-1504.